6-Fluoro-4-(trifluoromethyl)quinolin-2(1H)-one, 95.0%, 250mg

3-(2-Nitrophenyl)acrylic acid, 95.0%, 500g

2,4-Dichloro-5-nitrotoluene, 95%, 100g

2-hydroxy-N-(4H-1,2,4-triazol-3-yl)benzamide, 97%, 1g

(3-Oxopiperazin-2-yl)acetic acid, 97.0%, 1g

(2R,3R,4S,5R)-2-(6-Amino-8-bromo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 1g

Sodium heptane-1-sulfonate monohydrate, 95.0%, 100g

(S)-1-(Pyridin-3-yl)ethanamine, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

Ethanol, 2-[2-[2-[2-(aminooxy)ethoxy]ethoxy]ethoxy]-, 95%, 100mg

250 ml square bottle HDPE natural OV 32 square

N-(3-Chloro-4-methoxyphenyl)-2-cyanoacetamide, 97%, 100mg

2-Bromo-4-chloroiodobenzene, 97.0%, 10g